Envestnet Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24M Sell
1,432,473
-489,289
-25% -$8.2M 0.01% 1136
2025
Q1
$29.5M Sell
1,921,762
-116,779
-6% -$1.79M 0.01% 954
2024
Q4
$44.9M Sell
2,038,541
-68,650
-3% -$1.51M 0.01% 770
2024
Q3
$38M Buy
2,107,191
+30,591
+1% +$551K 0.01% 845
2024
Q2
$33.7M Buy
2,076,600
+207,533
+11% +$3.37M 0.01% 844
2024
Q1
$26.4M Buy
1,869,067
+1,797,750
+2,521% +$25.4M 0.01% 953
2023
Q4
$745K Buy
71,317
+29,948
+72% +$313K ﹤0.01% 3116
2023
Q3
$422K Sell
41,369
-128,693
-76% -$1.31M ﹤0.01% 3338
2023
Q2
$1.28M Sell
170,062
-801,022
-82% -$6.03M ﹤0.01% 2563
2023
Q1
$2.11M Buy
971,084
+658,396
+211% +$1.43M ﹤0.01% 2169
2022
Q4
$2.85M Sell
312,688
-94,765
-23% -$864K ﹤0.01% 1939
2022
Q3
$3.29M Buy
407,453
+266,428
+189% +$2.15M ﹤0.01% 1776
2022
Q2
$1.06M Buy
141,025
+57,121
+68% +$430K ﹤0.01% 2544
2022
Q1
$788K Buy
83,904
+51,513
+159% +$484K ﹤0.01% 2833
2021
Q4
$259K Sell
32,391
-9,415
-23% -$75.3K ﹤0.01% 3498
2021
Q3
$407K Buy
41,806
+3,234
+8% +$31.5K ﹤0.01% 3104
2021
Q2
$382K Sell
38,572
-27,282
-41% -$270K ﹤0.01% 3139
2021
Q1
$760K Sell
65,854
-31,439
-32% -$363K ﹤0.01% 2595
2020
Q4
$939K Buy
97,293
+13,812
+17% +$133K ﹤0.01% 2253
2020
Q3
$752K Buy
83,481
+68,147
+444% +$614K ﹤0.01% 2198
2020
Q2
$189K Buy
15,334
+2,389
+18% +$29.4K ﹤0.01% 2887
2020
Q1
$116K Sell
12,945
-553
-4% -$4.96K ﹤0.01% 2831
2019
Q4
$132K Buy
13,498
+1,574
+13% +$15.4K ﹤0.01% 2975
2019
Q3
$82K Buy
+11,924
New +$82K ﹤0.01% 2967
2019
Q2
Sell
-85,318
Closed -$1.34M 3074
2019
Q1
$1.34M Buy
85,318
+39,583
+87% +$621K ﹤0.01% 1710
2018
Q4
$705K Buy
+45,735
New +$705K ﹤0.01% 1940
2018
Q3
Sell
-1,729
Closed -$42K 2474
2018
Q2
$42K Buy
1,729
+731
+73% +$17.8K ﹤0.01% 2255
2018
Q1
$17K Sell
998
-9,394
-90% -$160K ﹤0.01% 2410
2017
Q4
$197K Sell
10,392
-11,520
-53% -$218K ﹤0.01% 1852
2017
Q3
$387K Sell
21,912
-10,844
-33% -$192K ﹤0.01% 1579
2017
Q2
$1.09M Sell
32,756
-4,645
-12% -$154K ﹤0.01% 1150
2017
Q1
$1.2M Sell
37,401
-68,798
-65% -$2.2M ﹤0.01% 1137
2016
Q4
$3.85M Sell
106,199
-60,146
-36% -$2.18M 0.01% 639
2016
Q3
$7.65M Sell
166,345
-124,296
-43% -$5.72M 0.03% 437
2016
Q2
$14.6M Sell
290,641
-8,890
-3% -$447K 0.06% 283
2016
Q1
$16M Buy
299,531
+63,677
+27% +$3.41M 0.07% 245
2015
Q4
$15.5M Sell
235,854
-8,960
-4% -$588K 0.07% 250
2015
Q3
$13.8M Buy
244,814
+23,152
+10% +$1.31M 0.07% 239
2015
Q2
$13.1M Buy
221,662
+9,023
+4% +$533K 0.06% 285
2015
Q1
$13.2M Buy
212,639
+205,157
+2,742% +$12.8M 0.07% 277
2014
Q4
$430K Buy
7,482
+131
+2% +$7.53K ﹤0.01% 746
2014
Q3
$395K Buy
7,351
+437
+6% +$23.5K ﹤0.01% 847
2014
Q2
$362K Sell
6,914
-3,042
-31% -$159K ﹤0.01% 838
2014
Q1
$526K Sell
9,956
-958
-9% -$50.6K 0.01% 642
2013
Q4
$437K Sell
10,914
-891
-8% -$35.7K 0.01% 657
2013
Q3
$446K Buy
11,805
+1,726
+17% +$65.2K 0.01% 632
2013
Q2
$395K Buy
+10,079
New +$395K 0.01% 645